AI Article Synopsis
- Hyperlipidemia, an increased level of fats in the blood, is linked to a higher risk of developing osteoarthritis.
- A case report discusses a 40-year-old male who developed arthritis due to high cholesterol levels associated with diabetes mellitus.
- The report includes details about the cytological characteristics of the patient's synovial fluid, which helps understand the condition further.
Article Abstract
Hyperlipidemia is a risk factor of osteoarthritis. In the present case report, a case of hypercholesterolemic arthritis secondary to diabetes mellitus is described in a 40-year-old male along with the cytological features of synovial fluid.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586627 | PMC |
| http://dx.doi.org/10.4103/jfmpc.jfmpc_610_20 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of () sup. TISTR 2593 Probiotic Supplementation on the Gut Microbiome of Hypercholesterolemia Patients: A Randomized Controlled Trial.
Nutrients
September 2024
Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
Probiotics have shown potential in managing hypercholesterolemia and related metabolic conditions. This study evaluated the effects of ( sup. TISTR 2593 on the gut microbiome and metabolic health in patients with hypercholesterolemia, and was registered in the Thai Clinical Trial Registry (TCTR 20220917002).
View Article and Find Full Text PDFNutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial.
Adv Rheumatol
June 2024
Rheumatology Division, Paulista School of Medicine, Federal University of São Paulo, UNIFESP/EPM), Borges Lagoa Street, 913, room 53, Vila Clementino, São Paulo/SP, 04038-034, Brazil.
Introduction: Patients with psoriatic arthritis have some lipid metabolism changes and higher risk of metabolic syndrome (MetS) and cardiovascular diseases, regardless of traditional risk factors, suggesting that chronic inflammation itself plays a central role concerning the atherosclerosis. However, there is a lack of information regarding atherogenic pattern and lipoprotein subfractions burden in these individuals.
Aim: To evaluate the HDL and LDL-cholesterol plasmatic levels and their subfractions after a nutritional intervention in patients with psoriatic arthritis (PsA).
Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism.
Int J Mol Sci
August 2023
Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
The impact of JAK/STAT inhibitors, which are used in various inflammatory diseases, on cardiovascular risk is controversial and has recently raised safety concerns. Our study investigates the direct effects of tofacitinib on macrophage cholesterol metabolism, which is crucial for atherosclerosis plaque development and stability. Cultured human macrophages THP-1 were used to assess the impact of tofacitinib on cell cholesterol efflux and synthesis via radioisotopic methods, and on cholesterol uptake by measuring the cell cholesterol content with a fluorometric assay.
View Article and Find Full Text PDFTowards Developing Novel Prostate Cancer Recurrence Suppressors: Acute Toxicity of Pseurotin A, an Orally Active PCSK9 Axis-Targeting Small-Molecule in Swiss Albino Mice.
Molecules
February 2023
School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA.
The proprotein convertase subtilisin kexin type 9 (PCSK9) emerged as a molecular target of great interest for the management of cardiovascular disorders due to its ability to reduce low density lipoprotein (LDL) cholesterol by binding and targeting at LDLR for lysosomal degradation in cells. Preliminary studies revealed that pseurotin A (PsA), a spiro-heterocyclic γ-lactam alkaloid from several marine and terrestrial and species, has the ability to dually suppress the PCSK9 expression and protein-protein interaction (PPI) with LDLR, resulting in an anti-hypercholesterolemic effect and modulating the oncogenic role of PCSK9 axis in breast and prostate cancers progression and recurrence. Thus, a preliminary assessment of the PsA acute toxicity represents the steppingstone to develop PsA as a novel orally active PCSK9 axis modulating cancer recurrence inhibitor.
View Article and Find Full Text PDFHypercholesterolemic arthritis: A case report with emphasis on synovial fluid cytology.
J Family Med Prim Care
August 2020
Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
Article Synopsis
- Hyperlipidemia, an increased level of fats in the blood, is linked to a higher risk of developing osteoarthritis.
- A case report discusses a 40-year-old male who developed arthritis due to high cholesterol levels associated with diabetes mellitus.
- The report includes details about the cytological characteristics of the patient's synovial fluid, which helps understand the condition further.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!